Taysha Gene Therapies Presents Preclinical Data on TSHA-102 for Rett Syndrome…
<!-- Name:DistributionId Value:8842737 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Taysha
Taysha Gene Therapies Announces Presentation on New Preclinical Data for TSHA-102 in…
<!-- Name:DistributionId Value:8827686 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma’s Strategic…
DALLAS, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing…
Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell…
Chief Executive Officer, Chief Technical Officer, Chief Medical Officer and Head of Research and Development and Senior Vice President of Manufacturing to participate in a panel discussion…